Cairo University
Giza, Dokki, Egypt
Location status: Recruiting
NCT Number: NCT07277673
Cognitive Behavioural Treatment is used as treatment for Heavy Drinking, Impotence, and Metabolic Syndrome. The efficacy of adding aerobic training to this treatment is not tested till now.
Interested in participating?
Request Info35 year–45 year
Male
Interventional
Not applicable
Giza, Dokki, Egypt
Location status: Recruiting
Forty men with Heavy Drinking, Impotence, and Metabolic Syndrome will be included. catogorization will be performed to assign them to group number I or group number II. Every group will involve/contain twenty males. Both groups will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, Group number I will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session , three times/week, for 12 weeks).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, men will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session, three times/week, for 12 weeks).
Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks)
Time frame: it will be measured after 12 weeks
it contain 5 questions that will assess penile erectile functions
Time frame: It will be measured after 12 weeks
it will be assessed on empty stomach and empty bladder and empty bowel
Time frame: It will be measured after 12 weeks
it will be assessed at ubmlilicus by a tape
Time frame: It will be measured after 12 weeks
it will be assessed via sphygmonameter
Time frame: it will be measured after 12 weeks
it will be assessed via sphygmonameter
Time frame: It will be measured after 12 weeks
it will be assessed in plasma
Time frame: It will be measured after 12 weeks
it will be assessed via plasma
Time frame: It will be measured after 12 weeks
it will assessed vin fasting plasma
Time frame: It will be measured after 12 weeks
the total score of this questionaire will be estimated
Time frame: It will be measured after 12 weeks
a subscomponent of Alcohol-abstinence self-efficacy questioannire
Time frame: It will be measured after 12 weeks
a subscomponent of Alcohol-abstinence self-efficacy questioannire
Time frame: It will be measured after 12 weeks
a subscomponent of Alcohol-abstinence self-efficacy questioannire
Time frame: It will be measured after 12 weeks
a subscomponent of Alcohol-abstinence self-efficacy questioannire
Time frame: It will be measured after 12 weeks
the total score of this questioannaire that contin 21 questions will be scored
Contact information is provided by the study sponsor or research team.
Ali MA Ismail, lecturer
CONTACT
Ali Mohamed, lecturer
CONTACT
Cairo University
Other
Is There a Benefit of Aerobic Exercise Addition to Cognitive Behavioural Treatment in Heavy Drinking Men With Impotence and Metabolic Syndrome?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05509166
Heavy Drinking, Mental Health Issue
New York, United States
View Trial DetailsNCT07591428
Alcohol Drinking, Alcohol-Related Disorders
Tulsa, Oklahoma, United States
View Trial DetailsNCT07516873
Heavy Drinking
Malden, Massachusetts, United States
View Trial DetailsNCT05491551
Alcohol Drinking, Alcohol-Related Disorders
Berkeley, California, United States
View Trial Details